Solar Biotech's Post-Sale Ch. 11 Liquidation Gets OK
A Delaware bankruptcy judge said Tuesday she would approve the Chapter 11 liquidation plan of Solar Biotech Inc. after it sold its assets for $20 million and resolved litigation between its largest secured...To view the full article, register now.
Already a subscriber? Click here to view full article